MedTrace Logo

The Glucose Transporter Type I Deficiency (G1D) Registry

NCT02013583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 471

Last updated 2025-03-07

No results posted yet for this study

Summary

The purpose of this protocol is to create a registry for patients diagnosed with Glucose Transporter Type 1 Deficiency (G1D), or patients experiencing symptoms consistent with G1D but not yet diagnosed, to enter medical information for physicians and other health researchers to analyze to increase the understanding of G1D and any sub-diagnoses.

Conditions

  • GLUT1 Deficiency Syndrome
  • Glucose Transporter Type 1 Deficiency Syndrome
  • Glucose Transporter Type1 (GLUT-1) Deficiency
  • GLUT-1 Deficiency Syndrome

Interventions

OTHER

No intervention

This is an observational registry. No interventions are required or provided.

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Juan M. Pascual, MD, PhD · UT Southwestern Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2024-08-01
Completion
2024-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02013583 on ClinicalTrials.gov